Plain-English translation of NCT07660263 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Stroke research guide →This research study is trying to understand why some people develop dementia after a stroke, while others don't. Researchers will collect blood samples for genetic testing, perform brain scans, measure brain activity, and test your thinking and memory skills over time. By combining all this information, they hope to create a prediction tool that can identify which stroke survivors are most likely to develop dementia — so doctors can monitor and help them more effectively.
After a stroke, some people experience decline in thinking and memory skills, while others recover well. Right now, doctors don't have a reliable way to predict who will develop this type of dementia. This study aims to fill that gap by finding the genetic and biological patterns that put people at higher risk, which could lead to better, more personalized care.
You likely qualify if…
You likely don't qualify if…
If you're a stroke survivor, you'll be enrolled at different time points after your stroke — from 1 week to 3 years afterward — and followed for up to 36 months. If you're a healthy control, you'll have baseline and follow-up visits. At visits, you'll donate blood for genetic testing, undergo brain imaging (MRI), have brain activity measured with special sensors, take cognitive and memory tests, and answer questions about your daily functioning. The study team will track changes in your thinking and memory over time.
AI-generated summary from trial data · Nov 4, 2026 · Not medical advice
South Korea
Sponsor
Seyoung Shin
Enrollment target
~300 participants
Started
July 2026
Primary completion
December 2030
Age range
19 Years and older
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Seyoung Shin, MD
Seyoung Shin
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.